inavo, palbo plus fulv sees sustained benefit beyond disease progression in her2‑negative locall...
Published 3 months ago • 55 plays • Length 4:11Download video MP4
Download video MP3
Similar videos
-
7:27
polaris: palbociclib for bipoc patients with her2-negative breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
4:16
durvalumab and oleclumab boost for sbrt plus chemo in er /her2- breast cancer
-
8:25
paloma-1 study of palbociclib in er , her2-, breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
7:09
palbociclib endocrine therapy vs capecitabine for hr-positive her2-negative breast cancer: pearl
-
9:54
palbociclib endocrine therapy for hormone-positive her2-negative metastatic breast cancer: 5 cases
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
4:16
fulvestrant with or without palbociclib in receptor-positive, her2-negative metastatic breast cancer
-
1:17
new breast cancer clinical trial: aspirin for node positive her2 negative breast cancer
-
0:39
exploring the science of il8 cytokine activation in her2 positive breast cancer #il8 #her2
-
1:36
an overview of the meribel study in her2-negative breast cancer
-
0:59
dr. varella on the results of monaleesa-7 in hr /her2- breast cancer
-
1:51
ameera-3: serd for er her2- breast cancer
-
4:45
giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, her2-negative...